Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Cigna Corporation’s Short Term Rating Analysis

|Includes: Cigna Corp. (CI)

Cigna sees a drop of 4.88% and received a ranking of 2 by 12 brokerage firms.

The shares of Cigna Corporation dropped by 4.88% at a share price of $135.75 due to which a decline was seen in the market capital of the global health services firm.

The trading session commenced with a share price of $127.3 and was seen hit a high point of $140.35 and a low point of $124.17. The volume of the shares by the ended of the session was at 3,486,229 with a last share of price $135.75. The firm's one year low share price was seen at 85.75 and was registered on October 15, 2014 and a one year high share price of $170.68 was registered at June 26, 2015.

The price target set by 11 analysts of the health services company in the short term was at $150.89. With an estimated standard deviation of $25.66 which suggested that the estimated price target is likely to fluctuate with this value. The higher price target was estimated at $190 and the lower price target was estimated at $115. The past four weeks the firm's stock has dropped by 6.84% whereas the firm's shares in the past five trading days have declined by 7.39%. The stock performance since the past year stands at 31.95%; in the last three months the shares went up by 1.37%.

The rating that the company received from almost 12 brokerage firms is at 2. While the analysts at Zacks have also given a rank of 2 with suggesting the traders to Buy the shares in the short term. According to 6 Wall Street stock analysts the company stands at a rating of Hold while the other 6 gave it a rating of Strong Buy.

In other news on Cigna, the company has named Greg Allen as the new President of the health services company on August 19, 2015 for the Tennessee Market, whose sole purpose will be to take care of the leadership responsibilities given to him by the company and manage its products and services in the state of Tennessee. The company is a health services company which is dedicated to improving people's health by helping them. The company's subsidies itself provides all the services and products to the market.

HealthSpring of Cigna Corp President, Herbert A Fritch on August 17, 2015 sold 38,489 share of $144.53 per share. The total transaction was worth $5,556,230.50. This Insider buying and selling information was disclosed to Securities and Exchange Commission by the company on August 19, 2015 on a Form 4 filing. Currently the company has a recommendation consensus of Buy.